Low Level Laser Therapy for Bowel Incontinence
(LLLT-FI Trial)
Trial Summary
If you are taking steroids, you will need to stop them to participate in this trial.
Research shows that Low Level Laser Therapy (LLLT) helps with wound healing, reduces inflammation, and relieves pain by promoting cell growth and repair. While these studies focus on wound healing, the positive effects on tissue repair and inflammation suggest potential benefits for other conditions, like bowel incontinence.
12345Low level laser therapy (LLLT) is unique because it uses light to stimulate biological processes in cells, promoting tissue repair and reducing inflammation, which is different from traditional treatments that may rely on medications or surgical interventions.
12346Eligibility Criteria
This trial is for individuals with severe fecal incontinence, which means they have trouble controlling their bowel movements. It's not open to pregnant people, those on steroids, anyone with active deep vein thrombosis or bleeding in the treatment area, light-sensitive patients, or if there are tattoos or known cancers where the therapy will be applied.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive low level laser therapy for fecal incontinence over 3 weeks, with a total of 8 sessions
Follow-up
Participants are monitored for changes in fecal incontinence episodes, symptoms score, and quality of life at 4 and 12 weeks after the start of treatment
Participant Groups
Low level laser therapy (LLLT) is already approved in United States, Canada, European Union for the following indications:
- Pain relief
- Wound healing
- Musculoskeletal conditions
- Fecal incontinence (investigational)
- Pain relief
- Wound healing
- Musculoskeletal conditions
- Pain relief
- Wound healing
- Musculoskeletal conditions